Summary
Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.
The Live Cell Encapsulation industry can be broken down into several segments, Alginate, HEMA-MMA, etc.
Across the world, the major players cover BioTime, Reed Pacific, Viacyte, etc.
According to APO Research, The global Live Cell Encapsulation market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Live Cell Encapsulation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Live Cell Encapsulation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Live Cell Encapsulation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Live Cell Encapsulation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Live Cell Encapsulation include Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc. and Altucell, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Live Cell Encapsulation, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Live Cell Encapsulation, also provides the revenue of main regions and countries. Of the upcoming market potential for Live Cell Encapsulation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Live Cell Encapsulation revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Live Cell Encapsulation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Live Cell Encapsulation revenue, projected growth trends, production technology, application and end-user industry.
Live Cell Encapsulation segment by Company
Viacyte, Inc.
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
PharmaCyte Biotech Inc
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd
Live Cell Encapsulation segment by Type
Alginate
Chitosan
Cellulose
Others
Live Cell Encapsulation segment by Application
Diabetes
Cancer
Epilepsy
Parkinson
Others
Live Cell Encapsulation segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Live Cell Encapsulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Live Cell Encapsulation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Live Cell Encapsulation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Live Cell Encapsulation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Live Cell Encapsulation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Live Cell Encapsulation revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Live Cell Encapsulation Market by Type
1.2.1 Global Live Cell Encapsulation Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Alginate
1.2.3 Chitosan
1.2.4 Cellulose
1.2.5 Others
1.3 Live Cell Encapsulation Market by Application
1.3.1 Global Live Cell Encapsulation Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Diabetes
1.3.3 Cancer
1.3.4 Epilepsy
1.3.5 Parkinson
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Live Cell Encapsulation Market Dynamics
2.1 Live Cell Encapsulation Industry Trends
2.2 Live Cell Encapsulation Industry Drivers
2.3 Live Cell Encapsulation Industry Opportunities and Challenges
2.4 Live Cell Encapsulation Industry Restraints
3 Global Growth Perspective
3.1 Global Live Cell Encapsulation Market Perspective (2019-2030)
3.2 Global Live Cell Encapsulation Growth Trends by Region
3.2.1 Global Live Cell Encapsulation Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Live Cell Encapsulation Market Size by Region (2019-2024)
3.2.3 Global Live Cell Encapsulation Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Live Cell Encapsulation Revenue by Players
4.1.1 Global Live Cell Encapsulation Revenue by Players (2019-2024)
4.1.2 Global Live Cell Encapsulation Revenue Market Share by Players (2019-2024)
4.1.3 Global Live Cell Encapsulation Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Live Cell Encapsulation Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Live Cell Encapsulation Key Players Headquarters & Area Served
4.4 Global Live Cell Encapsulation Players, Product Type & Application
4.5 Global Live Cell Encapsulation Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Live Cell Encapsulation Market CR5 and HHI
4.6.2 Global Top 5 and 10 Live Cell Encapsulation Players Market Share by Revenue in 2023
4.6.3 2023 Live Cell Encapsulation Tier 1, Tier 2, and Tier 3
5 Live Cell Encapsulation Market Size by Type
5.1 Global Live Cell Encapsulation Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Live Cell Encapsulation Revenue by Type (2019-2030)
5.3 Global Live Cell Encapsulation Revenue Market Share by Type (2019-2030)
6 Live Cell Encapsulation Market Size by Application
6.1 Global Live Cell Encapsulation Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Live Cell Encapsulation Revenue by Application (2019-2030)
6.3 Global Live Cell Encapsulation Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Viacyte, Inc.
7.1.1 Viacyte, Inc. Comapny Information
7.1.2 Viacyte, Inc. Business Overview
7.1.3 Viacyte, Inc. Live Cell Encapsulation Revenue and Gross Margin (2019-2024)
7.1.4 Viacyte, Inc. Live Cell Encapsulation Product Portfolio
7.1.5 Viacyte, Inc. Recent Developments
7.2 Living Cell Technologies Ltd.
7.2.1 Living Cell Technologies Ltd. Comapny Information
7.2.2 Living Cell Technologies Ltd. Business Overview
7.2.3 Living Cell Technologies Ltd. Live Cell Encapsulation Revenue and Gross Margin (2019-2024)
7.2.4 Living Cell Technologies Ltd. Live Cell Encapsulation Product Portfolio
7.2.5 Living Cell Technologies Ltd. Recent Developments
7.3 Sigilon Therapeutics, Inc
7.3.1 Sigilon Therapeutics, Inc Comapny Information
7.3.2 Sigilon Therapeutics, Inc Business Overview
7.3.3 Sigilon Therapeutics, Inc Live Cell Encapsulation Revenue and Gross Margin (2019-2024)
7.3.4 Sigilon Therapeutics, Inc Live Cell Encapsulation Product Portfolio
7.3.5 Sigilon Therapeutics, Inc Recent Developments
7.4 Sernova Corporation
7.4.1 Sernova Corporation Comapny Information
7.4.2 Sernova Corporation Business Overview
7.4.3 Sernova Corporation Live Cell Encapsulation Revenue and Gross Margin (2019-2024)
7.4.4 Sernova Corporation Live Cell Encapsulation Product Portfolio
7.4.5 Sernova Corporation Recent Developments
7.5 PharmaCyte Biotech Inc
7.5.1 PharmaCyte Biotech Inc Comapny Information
7.5.2 PharmaCyte Biotech Inc Business Overview
7.5.3 PharmaCyte Biotech Inc Live Cell Encapsulation Revenue and Gross Margin (2019-2024)
7.5.4 PharmaCyte Biotech Inc Live Cell Encapsulation Product Portfolio
7.5.5 PharmaCyte Biotech Inc Recent Developments
7.6 Gloriana Therapeutics
7.6.1 Gloriana Therapeutics Comapny Information
7.6.2 Gloriana Therapeutics Business Overview
7.6.3 Gloriana Therapeutics Live Cell Encapsulation Revenue and Gross Margin (2019-2024)
7.6.4 Gloriana Therapeutics Live Cell Encapsulation Product Portfolio
7.6.5 Gloriana Therapeutics Recent Developments
7.7 Kadimastem
7.7.1 Kadimastem Comapny Information
7.7.2 Kadimastem Business Overview
7.7.3 Kadimastem Live Cell Encapsulation Revenue and Gross Margin (2019-2024)
7.7.4 Kadimastem Live Cell Encapsulation Product Portfolio
7.7.5 Kadimastem Recent Developments
7.8 Beta-O2 Technologies, Inc.
7.8.1 Beta-O2 Technologies, Inc. Comapny Information
7.8.2 Beta-O2 Technologies, Inc. Business Overview
7.8.3 Beta-O2 Technologies, Inc. Live Cell Encapsulation Revenue and Gross Margin (2019-2024)
7.8.4 Beta-O2 Technologies, Inc. Live Cell Encapsulation Product Portfolio
7.8.5 Beta-O2 Technologies, Inc. Recent Developments
7.9 Altucell, Inc.
7.9.1 Altucell, Inc. Comapny Information
7.9.2 Altucell, Inc. Business Overview
7.9.3 Altucell, Inc. Live Cell Encapsulation Revenue and Gross Margin (2019-2024)
7.9.4 Altucell, Inc. Live Cell Encapsulation Product Portfolio
7.9.5 Altucell, Inc. Recent Developments
7.10 Diatranz Otsuka Ltd
7.10.1 Diatranz Otsuka Ltd Comapny Information
7.10.2 Diatranz Otsuka Ltd Business Overview
7.10.3 Diatranz Otsuka Ltd Live Cell Encapsulation Revenue and Gross Margin (2019-2024)
7.10.4 Diatranz Otsuka Ltd Live Cell Encapsulation Product Portfolio
7.10.5 Diatranz Otsuka Ltd Recent Developments
8 North America
8.1 North America Live Cell Encapsulation Revenue (2019-2030)
8.2 North America Live Cell Encapsulation Revenue by Type (2019-2030)
8.2.1 North America Live Cell Encapsulation Revenue by Type (2019-2024)
8.2.2 North America Live Cell Encapsulation Revenue by Type (2025-2030)
8.3 North America Live Cell Encapsulation Revenue Share by Type (2019-2030)
8.4 North America Live Cell Encapsulation Revenue by Application (2019-2030)
8.4.1 North America Live Cell Encapsulation Revenue by Application (2019-2024)
8.4.2 North America Live Cell Encapsulation Revenue by Application (2025-2030)
8.5 North America Live Cell Encapsulation Revenue Share by Application (2019-2030)
8.6 North America Live Cell Encapsulation Revenue by Country
8.6.1 North America Live Cell Encapsulation Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Live Cell Encapsulation Revenue by Country (2019-2024)
8.6.3 North America Live Cell Encapsulation Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Live Cell Encapsulation Revenue (2019-2030)
9.2 Europe Live Cell Encapsulation Revenue by Type (2019-2030)
9.2.1 Europe Live Cell Encapsulation Revenue by Type (2019-2024)
9.2.2 Europe Live Cell Encapsulation Revenue by Type (2025-2030)
9.3 Europe Live Cell Encapsulation Revenue Share by Type (2019-2030)
9.4 Europe Live Cell Encapsulation Revenue by Application (2019-2030)
9.4.1 Europe Live Cell Encapsulation Revenue by Application (2019-2024)
9.4.2 Europe Live Cell Encapsulation Revenue by Application (2025-2030)
9.5 Europe Live Cell Encapsulation Revenue Share by Application (2019-2030)
9.6 Europe Live Cell Encapsulation Revenue by Country
9.6.1 Europe Live Cell Encapsulation Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Live Cell Encapsulation Revenue by Country (2019-2024)
9.6.3 Europe Live Cell Encapsulation Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Live Cell Encapsulation Revenue (2019-2030)
10.2 China Live Cell Encapsulation Revenue by Type (2019-2030)
10.2.1 China Live Cell Encapsulation Revenue by Type (2019-2024)
10.2.2 China Live Cell Encapsulation Revenue by Type (2025-2030)
10.3 China Live Cell Encapsulation Revenue Share by Type (2019-2030)
10.4 China Live Cell Encapsulation Revenue by Application (2019-2030)
10.4.1 China Live Cell Encapsulation Revenue by Application (2019-2024)
10.4.2 China Live Cell Encapsulation Revenue by Application (2025-2030)
10.5 China Live Cell Encapsulation Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Live Cell Encapsulation Revenue (2019-2030)
11.2 Asia Live Cell Encapsulation Revenue by Type (2019-2030)
11.2.1 Asia Live Cell Encapsulation Revenue by Type (2019-2024)
11.2.2 Asia Live Cell Encapsulation Revenue by Type (2025-2030)
11.3 Asia Live Cell Encapsulation Revenue Share by Type (2019-2030)
11.4 Asia Live Cell Encapsulation Revenue by Application (2019-2030)
11.4.1 Asia Live Cell Encapsulation Revenue by Application (2019-2024)
11.4.2 Asia Live Cell Encapsulation Revenue by Application (2025-2030)
11.5 Asia Live Cell Encapsulation Revenue Share by Application (2019-2030)
11.6 Asia Live Cell Encapsulation Revenue by Country
11.6.1 Asia Live Cell Encapsulation Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Live Cell Encapsulation Revenue by Country (2019-2024)
11.6.3 Asia Live Cell Encapsulation Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Live Cell Encapsulation Revenue (2019-2030)
12.2 MEALA Live Cell Encapsulation Revenue by Type (2019-2030)
12.2.1 MEALA Live Cell Encapsulation Revenue by Type (2019-2024)
12.2.2 MEALA Live Cell Encapsulation Revenue by Type (2025-2030)
12.3 MEALA Live Cell Encapsulation Revenue Share by Type (2019-2030)
12.4 MEALA Live Cell Encapsulation Revenue by Application (2019-2030)
12.4.1 MEALA Live Cell Encapsulation Revenue by Application (2019-2024)
12.4.2 MEALA Live Cell Encapsulation Revenue by Application (2025-2030)
12.5 MEALA Live Cell Encapsulation Revenue Share by Application (2019-2030)
12.6 MEALA Live Cell Encapsulation Revenue by Country
12.6.1 MEALA Live Cell Encapsulation Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Live Cell Encapsulation Revenue by Country (2019-2024)
12.6.3 MEALA Live Cell Encapsulation Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Live Cell Encapsulation Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Alginate Major Manufacturers
Table 2. Chitosan Major Manufacturers
Table 3. Cellulose Major Manufacturers
Table 4. Others Major Manufacturers
Table 5. Global Live Cell Encapsulation Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Diabetes Major Manufacturers
Table 7. Cancer Major Manufacturers
Table 8. Epilepsy Major Manufacturers
Table 9. Parkinson Major Manufacturers
Table 10. Others Major Manufacturers
Table 11. Live Cell Encapsulation Industry Trends
Table 12. Live Cell Encapsulation Industry Drivers
Table 13. Live Cell Encapsulation Industry Opportunities and Challenges
Table 14. Live Cell Encapsulation Industry Restraints
Table 15. Global Live Cell Encapsulation Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 16. Global Live Cell Encapsulation Market Size by Region (2019-2024) & (US$ Million)
Table 17. Global Live Cell Encapsulation Market Share by Region (2019-2024)
Table 18. Global Live Cell Encapsulation Market Size by Region (2025-2030) & (US$ Million)
Table 19. Global Live Cell Encapsulation Market Share by Region (2025-2030)
Table 20. Global Live Cell Encapsulation Revenue by Players (US$ Million) & (2019-2024)
Table 21. Global Live Cell Encapsulation Revenue Market Share by Players (2019-2024)
Table 22. Global Live Cell Encapsulation Key Players Ranking, 2022 VS 2023 VS 2024
Table 23. Global Live Cell Encapsulation Key Players Headquarters & Area Served
Table 24. Global Live Cell Encapsulation Players, Product Type & Application
Table 25. Global Live Cell Encapsulation Players Commercialization Time
Table 26. Global Players Market Concentration Ratio (CR5 and HHI)
Table 27. Global Live Cell Encapsulation by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 28. Global Live Cell Encapsulation Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Live Cell Encapsulation Revenue by Type (2019-2024) & (US$ Million)
Table 30. Global Live Cell Encapsulation Revenue by Type (2025-2030) & (US$ Million)
Table 31. Global Live Cell Encapsulation Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 32. Global Live Cell Encapsulation Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 33. Global Live Cell Encapsulation Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Global Live Cell Encapsulation Revenue by Application (2019-2024) & (US$ Million)
Table 35. Global Live Cell Encapsulation Revenue by Application (2025-2030) & (US$ Million)
Table 36. Global Live Cell Encapsulation Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 37. Global Live Cell Encapsulation Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 38. Viacyte, Inc. Company Information
Table 39. Viacyte, Inc. Business Overview
Table 40. Viacyte, Inc. Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 41. Viacyte, Inc. Live Cell Encapsulation Product Portfolio
Table 42. Viacyte, Inc. Recent Development
Table 43. Living Cell Technologies Ltd. Company Information
Table 44. Living Cell Technologies Ltd. Business Overview
Table 45. Living Cell Technologies Ltd. Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 46. Living Cell Technologies Ltd. Live Cell Encapsulation Product Portfolio
Table 47. Living Cell Technologies Ltd. Recent Development
Table 48. Sigilon Therapeutics, Inc Company Information
Table 49. Sigilon Therapeutics, Inc Business Overview
Table 50. Sigilon Therapeutics, Inc Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 51. Sigilon Therapeutics, Inc Live Cell Encapsulation Product Portfolio
Table 52. Sigilon Therapeutics, Inc Recent Development
Table 53. Sernova Corporation Company Information
Table 54. Sernova Corporation Business Overview
Table 55. Sernova Corporation Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 56. Sernova Corporation Live Cell Encapsulation Product Portfolio
Table 57. Sernova Corporation Recent Development
Table 58. PharmaCyte Biotech Inc Company Information
Table 59. PharmaCyte Biotech Inc Business Overview
Table 60. PharmaCyte Biotech Inc Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 61. PharmaCyte Biotech Inc Live Cell Encapsulation Product Portfolio
Table 62. PharmaCyte Biotech Inc Recent Development
Table 63. Gloriana Therapeutics Company Information
Table 64. Gloriana Therapeutics Business Overview
Table 65. Gloriana Therapeutics Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 66. Gloriana Therapeutics Live Cell Encapsulation Product Portfolio
Table 67. Gloriana Therapeutics Recent Development
Table 68. Kadimastem Company Information
Table 69. Kadimastem Business Overview
Table 70. Kadimastem Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 71. Kadimastem Live Cell Encapsulation Product Portfolio
Table 72. Kadimastem Recent Development
Table 73. Beta-O2 Technologies, Inc. Company Information
Table 74. Beta-O2 Technologies, Inc. Business Overview
Table 75. Beta-O2 Technologies, Inc. Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 76. Beta-O2 Technologies, Inc. Live Cell Encapsulation Product Portfolio
Table 77. Beta-O2 Technologies, Inc. Recent Development
Table 78. Altucell, Inc. Company Information
Table 79. Altucell, Inc. Business Overview
Table 80. Altucell, Inc. Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 81. Altucell, Inc. Live Cell Encapsulation Product Portfolio
Table 82. Altucell, Inc. Recent Development
Table 83. Diatranz Otsuka Ltd Company Information
Table 84. Diatranz Otsuka Ltd Business Overview
Table 85. Diatranz Otsuka Ltd Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 86. Diatranz Otsuka Ltd Live Cell Encapsulation Product Portfolio
Table 87. Diatranz Otsuka Ltd Recent Development
Table 88. North America Live Cell Encapsulation Revenue by Type (2019-2024) & (US$ Million)
Table 89. North America Live Cell Encapsulation Revenue by Application (2019-2024) & (US$ Million)
Table 90. North America Live Cell Encapsulation Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 91. North America Live Cell Encapsulation Revenue by Country (2019-2024) & (US$ Million)
Table 92. North America Live Cell Encapsulation Revenue by Country (2025-2030) & (US$ Million)
Table 93. Europe Live Cell Encapsulation Revenue by Type (2019-2024) & (US$ Million)
Table 94. Europe Live Cell Encapsulation Revenue by Application (2019-2024) & (US$ Million)
Table 95. Europe Live Cell Encapsulation Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 96. Europe Live Cell Encapsulation Revenue by Country (2019-2024) & (US$ Million)
Table 97. Europe Live Cell Encapsulation Revenue by Country (2025-2030) & (US$ Million)
Table 98. China Live Cell Encapsulation Revenue by Type (2019-2024) & (US$ Million)
Table 99. China Live Cell Encapsulation Revenue by Application (2019-2024) & (US$ Million)
Table 100. Asia Live Cell Encapsulation Revenue by Type (2019-2024) & (US$ Million)
Table 101. Asia Live Cell Encapsulation Revenue by Application (2019-2024) & (US$ Million)
Table 102. Asia Live Cell Encapsulation Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 103. Asia Live Cell Encapsulation Revenue by Country (2019-2024) & (US$ Million)
Table 104. Asia Live Cell Encapsulation Revenue by Country (2025-2030) & (US$ Million)
Table 105. MEALA Live Cell Encapsulation Revenue by Type (2019-2024) & (US$ Million)
Table 106. MEALA Live Cell Encapsulation Revenue by Application (2019-2024) & (US$ Million)
Table 107. MEALA Live Cell Encapsulation Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 108. MEALA Live Cell Encapsulation Revenue by Country (2019-2024) & (US$ Million)
Table 109. MEALA Live Cell Encapsulation Revenue by Country (2025-2030) & (US$ Million)
Table 110. Research Programs/Design for This Report
Table 111. Authors List of This Report
Table 112. Secondary Sources
Table 113. Primary Sources
List of Figures
Figure 1. Live Cell Encapsulation Product Picture
Figure 2. Global Live Cell Encapsulation Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Live Cell Encapsulation Market Size Share 2019 VS 2023 VS 2030
Figure 4. Alginate Picture
Figure 5. Chitosan Picture
Figure 6. Cellulose Picture
Figure 7. Others Picture
Figure 8. Global Live Cell Encapsulation Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 9. Global Live Cell Encapsulation Market Size Share 2019 VS 2023 VS 2030
Figure 10. Diabetes Picture
Figure 11. Cancer Picture
Figure 12. Epilepsy Picture
Figure 13. Parkinson Picture
Figure 14. Others Picture
Figure 15. Global Live Cell Encapsulation Market Size (US$ Million) & (2019-2030)
Figure 16. Global Live Cell Encapsulation Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Live Cell Encapsulation Market Share by Region: 2019 VS 2023 VS 2030
Figure 18. Global Live Cell Encapsulation Players Revenue Share Top 10 and Top 5 in 2023
Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Live Cell Encapsulation Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Live Cell Encapsulation Revenue Market Share 2019 VS 2023 VS 2030
Figure 22. Global Live Cell Encapsulation Revenue Market Share by Type (2019-2030)
Figure 23. Global Live Cell Encapsulation Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Live Cell Encapsulation Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 25. Global Live Cell Encapsulation Revenue Market Share by Application (2019-2030)
Figure 26. North America Live Cell Encapsulation Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 27. North America Live Cell Encapsulation Revenue by Type (2025-2030) & (US$ Million)
Figure 28. North America Live Cell Encapsulation Revenue Share by Type (2019-2030)
Figure 29. North America Live Cell Encapsulation Revenue by Application (2025-2030) & (US$ Million)
Figure 30. North America Live Cell Encapsulation Revenue Share by Application (2019-2030)
Figure 31. North America Live Cell Encapsulation Revenue Share by Country (2019-2030)
Figure 32. United States Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 33. Canada Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 34. Europe Live Cell Encapsulation Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 35. Europe Live Cell Encapsulation Revenue by Type (2025-2030) & (US$ Million)
Figure 36. Europe Live Cell Encapsulation Revenue Share by Type (2019-2030)
Figure 37. Europe Live Cell Encapsulation Revenue by Application (2025-2030) & (US$ Million)
Figure 38. Europe Live Cell Encapsulation Revenue Share by Application (2019-2030)
Figure 39. Europe Live Cell Encapsulation Revenue Share by Country (2019-2030)
Figure 40. Germany Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. France Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. U.K. Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. Italy Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. Russia Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 45. Nordic Countries Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 46. China Live Cell Encapsulation Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 47. China Live Cell Encapsulation Revenue by Type (2025-2030) & (US$ Million)
Figure 48. China Live Cell Encapsulation Revenue Share by Type (2019-2030)
Figure 49. China Live Cell Encapsulation Revenue by Application (2025-2030) & (US$ Million)
Figure 50. China Live Cell Encapsulation Revenue Share by Application (2019-2030)
Figure 51. Asia Live Cell Encapsulation Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 52. Asia Live Cell Encapsulation Revenue by Type (2025-2030) & (US$ Million)
Figure 53. Asia Live Cell Encapsulation Revenue Share by Type (2019-2030)
Figure 54. Asia Live Cell Encapsulation Revenue by Application (2025-2030) & (US$ Million)
Figure 55. Asia Live Cell Encapsulation Revenue Share by Application (2019-2030)
Figure 56. Asia Live Cell Encapsulation Revenue Share by Country (2019-2030)
Figure 57. Japan Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. South Korea Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. India Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. Australia Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. China Taiwan Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 62. Southeast Asia Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 63. MEALA Live Cell Encapsulation Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 64. MEALA Live Cell Encapsulation Revenue by Type (2025-2030) & (US$ Million)
Figure 65. MEALA Live Cell Encapsulation Revenue Share by Type (2019-2030)
Figure 66. MEALA Live Cell Encapsulation Revenue by Application (2025-2030) & (US$ Million)
Figure 67. MEALA Live Cell Encapsulation Revenue Share by Application (2019-2030)
Figure 68. MEALA Live Cell Encapsulation Revenue Share by Country (2019-2030)
Figure 69. Mexico Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. South Korea Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Brazil Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Israel Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Argentina Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Colombia Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. Turkey Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Saudi Arabia Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 77. UAE Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 78. Years Considered
Figure 79. Research Process
Figure 80. Key Executives Interviewed
